1. Home
  2. SLAB vs ICLR Comparison

SLAB vs ICLR Comparison

Compare SLAB & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silicon Laboratories Inc.

SLAB

Silicon Laboratories Inc.

HOLD

Current Price

$210.22

Market Cap

6.7B

Sector

Technology

ML Signal

HOLD

Logo ICON plc

ICLR

ICON plc

HOLD

Current Price

$106.27

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SLAB
ICLR
Founded
1996
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Commercial Physical & Biological Resarch
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
7.1B
IPO Year
2000
2001

Fundamental Metrics

Financial Performance
Metric
SLAB
ICLR
Price
$210.22
$106.27
Analyst Decision
Hold
Buy
Analyst Count
12
13
Target Price
$153.89
$178.62
AVG Volume (30 Days)
315.0K
773.6K
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
66.61
N/A
EPS
N/A
N/A
Revenue
$491,625,000.00
N/A
Revenue This Year
$20.49
N/A
Revenue Next Year
$16.65
N/A
P/E Ratio
N/A
$12.91
Revenue Growth
N/A
N/A
52 Week Low
$84.05
$66.57
52 Week High
$211.67
$211.00

Technical Indicators

Market Signals
Indicator
SLAB
ICLR
Relative Strength Index (RSI) 74.03 45.87
Support Level $204.63 $95.75
Resistance Level N/A $113.88
Average True Range (ATR) 1.78 4.98
MACD -0.40 1.70
Stochastic Oscillator 86.21 46.46

Price Performance

Historical Comparison
SLAB
ICLR

About SLAB Silicon Laboratories Inc.

Silicon Laboratories Inc Inc is a provider of secure, intelligent wireless technology for a more connected world. The company's integrated hardware and software platform, intuitive development tools, industry ecosystem, and robust support help customers build industrial, commercial, home, and life applications. Company make it easy for developers to solve complex wireless challenges throughout the product lifecycle and get to market quickly with solutions that transform industries, grow economies, and improve lives. Company operates in USA, China, Taiwan and Rest of World, with maximum revenue from rest of the world.

About ICLR ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Share on Social Networks: